Anticoagulant News and Research

RSS
Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Perioperative aspirin increases risk of serious bleeding after non-heart-related surgery

Perioperative aspirin increases risk of serious bleeding after non-heart-related surgery

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Poor blood pressure control increases stroke risk in patients with atrial fibrillation

Poor blood pressure control increases stroke risk in patients with atrial fibrillation

Genetic testing could help determine drug dosage, reduce side effects

Genetic testing could help determine drug dosage, reduce side effects

New case study reveals how to safely switch between anticoagulants for stroke prevention

New case study reveals how to safely switch between anticoagulants for stroke prevention

ATS develops clinical practice guidelines to help clinicians identify, manage patients with sickle cell disease

ATS develops clinical practice guidelines to help clinicians identify, manage patients with sickle cell disease

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Regado receives Fast Track designation from FDA for REG1

Regado receives Fast Track designation from FDA for REG1

Scientists describes new advantageous way to detect different immune cells in the blood

Scientists describes new advantageous way to detect different immune cells in the blood

Long-term risks of deep vein thrombosis

Long-term risks of deep vein thrombosis

New optical device may help docs to diagnose blood coagulation status in near real time

New optical device may help docs to diagnose blood coagulation status in near real time

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

AAN guideline suggests people with irregular heartbeat to take oral anticoagulants to prevent stroke

AAN guideline suggests people with irregular heartbeat to take oral anticoagulants to prevent stroke

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Researchers use cardiac monitor to assess atrial fibrillation after cryptogenic stroke

Study shows one-quarter of high risk patients do not receive anticoagulants after ablation of AF

Study shows one-quarter of high risk patients do not receive anticoagulants after ablation of AF

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.